APPRAISAL Trial: A phase IIa study to evaluate the safety and preliminary efficacy of RESTEN-MP [AVI 4126] when used in conjunction with a bare metal stent in de novo native coronary artery lesions
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2017
At a glance
- Drugs AVI 4126 (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms APPRAISAL
- Sponsors Sarepta Therapeutics
- 23 Aug 2007 Status changed from in progress to completed.
- 11 Jul 2007 Six-month follow-up data has been reported.
- 10 Jul 2007 Status changed from recruiting to in progress.